The Edison Biotechnology Institute Sponsored Seminar series presents “The Path to and from the Discovery of Transgenic Animals” on Wednesday, Nov. 12. Refreshments are at 3:30 p.m., and the seminar begins at 4 p.m. in the Konneker Research Center Room 100 at the Ridges.
Thomas E. Wagner
The speaker is Dr. Thomas E. Wagner CEO of Perseus PCI in Greenville, SC.
Abstract: The transgenic animal technology pioneered by Dr. Wagner a quarter century ago revolutionized biomedical research because it enabled the generation and frequent use of animal models for disease by introducing genetic changes into research animals. This technology remains a powerful tool in medical research that is used worldwide to investigate and develop treatments for major medical challenges. Dr. Wagner is also a strong advocate for entrepreneurship having been the co-‐founder of two start-‐up companies while at Ohio University, the inventor or co–inventor of numerous technologies protected by United States patents, and the founding director of the Edison Biotechnology Institute. At this 25th anniversary of his invention (the transgenic technology patent was granted on Oct. 10th, 1989), we would like to recognize his contributions to science, EBI, and technology discovery and entrepreneurship at Ohio University.
Comments